NO996313D0 - Nye amidinoderivater og deres anvendelse som trombininhibitorer - Google Patents
Nye amidinoderivater og deres anvendelse som trombininhibitorerInfo
- Publication number
- NO996313D0 NO996313D0 NO996313A NO996313A NO996313D0 NO 996313 D0 NO996313 D0 NO 996313D0 NO 996313 A NO996313 A NO 996313A NO 996313 A NO996313 A NO 996313A NO 996313 D0 NO996313 D0 NO 996313D0
- Authority
- NO
- Norway
- Prior art keywords
- thrombin inhibitors
- amidino derivatives
- novel amidino
- novel
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9702378A SE9702378D0 (sv) | 1997-06-19 | 1997-06-19 | New compounds |
SE9801099A SE9801099D0 (sv) | 1998-03-30 | 1998-03-30 | New compounds |
PCT/SE1998/001103 WO1998057932A1 (en) | 1997-06-19 | 1998-06-09 | New amidino derivatives and their use as thrombin inhibitors |
Publications (3)
Publication Number | Publication Date |
---|---|
NO996313D0 true NO996313D0 (no) | 1999-12-17 |
NO996313L NO996313L (no) | 2000-02-21 |
NO315156B1 NO315156B1 (no) | 2003-07-21 |
Family
ID=26663014
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19996313A NO315156B1 (no) | 1997-06-19 | 1999-12-17 | Nye amidinoderivater og deres anvendelse som trombininhibitorer, farmasöytisk formulering inneholdende slike derivater, deres anvendelse, ogfremgangsmåtefor deres fremstilling |
Country Status (20)
Country | Link |
---|---|
US (2) | US6265397B1 (no) |
EP (1) | EP1012140B1 (no) |
JP (2) | JP3919236B2 (no) |
KR (1) | KR100540413B1 (no) |
CN (1) | CN1205187C (no) |
AR (1) | AR013084A1 (no) |
AT (1) | ATE277902T1 (no) |
AU (1) | AU737645C (no) |
BR (1) | BR9810177A (no) |
CA (1) | CA2294059C (no) |
DE (1) | DE69826693T2 (no) |
EE (1) | EE9900600A (no) |
IL (1) | IL133490A0 (no) |
IS (1) | IS5302A (no) |
NO (1) | NO315156B1 (no) |
NZ (1) | NZ501635A (no) |
PL (1) | PL337645A1 (no) |
SK (1) | SK167099A3 (no) |
TR (1) | TR199903134T2 (no) |
WO (1) | WO1998057932A1 (no) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR013084A1 (es) * | 1997-06-19 | 2000-12-13 | Astrazeneca Ab | Derivados de amidino utiles como inhibidores de la trombina, composicion farmaceutica, utilizacion de dichos compuestos para la preparacion demedicamentos y proceso para la preparacion de los compuestos mencionados |
SE9704543D0 (sv) | 1997-12-05 | 1997-12-05 | Astra Ab | New compounds |
SE9804313D0 (sv) * | 1998-12-14 | 1998-12-14 | Astra Ab | New compounds |
EP1150996B1 (en) | 1999-01-13 | 2007-11-21 | AstraZeneca AB | New amidinobenzylamine derivatives and their use as thrombin inhibitors |
AR023510A1 (es) | 1999-04-21 | 2002-09-04 | Astrazeneca Ab | Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina. |
EP1059302A1 (en) * | 1999-06-08 | 2000-12-13 | Aventis Pharma Deutschland GmbH | Factor VIIa inhibitors |
SE0000382D0 (sv) | 2000-02-07 | 2000-02-07 | Astrazeneca Ab | New process |
US6403818B1 (en) | 2000-02-28 | 2002-06-11 | Eisai Co., Ltd. | Process for producing α-hydroxy-carbonyl compound |
SE0001803D0 (sv) | 2000-05-16 | 2000-05-16 | Astrazeneca Ab | New compounds i |
US6433186B1 (en) | 2000-08-16 | 2002-08-13 | Astrazeneca Ab | Amidino derivatives and their use as thormbin inhibitors |
US7129233B2 (en) * | 2000-12-01 | 2006-10-31 | Astrazeneca Ab | Mandelic acid derivatives and their use as thrombin inhibitors |
AR035216A1 (es) * | 2000-12-01 | 2004-05-05 | Astrazeneca Ab | Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios |
WO2002088298A1 (en) | 2001-04-27 | 2002-11-07 | The Procter & Gamble Company | Compounds, compositions, and methods for controlling biofilms |
AR034517A1 (es) * | 2001-06-21 | 2004-02-25 | Astrazeneca Ab | Formulacion farmaceutica |
SE0201661D0 (sv) | 2002-05-31 | 2002-05-31 | Astrazeneca Ab | New salts |
SE0201659D0 (sv) | 2002-05-31 | 2002-05-31 | Astrazeneca Ab | Modified release pharmaceutical formulation |
US7723349B2 (en) | 2003-04-24 | 2010-05-25 | Incyte Corporation | Aza spiro alkane derivatives as inhibitors of metalloproteases |
US7781424B2 (en) * | 2003-05-27 | 2010-08-24 | Astrazeneca Ab | Modified release pharmaceutical formulation |
DE602004008959T2 (de) * | 2003-11-07 | 2008-06-19 | F. Hoffmann-La Roche Ag | Benzoäbüä1,4üdioxepinderivate |
US7524354B2 (en) * | 2005-07-07 | 2009-04-28 | Research Foundation Of State University Of New York | Controlled synthesis of highly monodispersed gold nanoparticles |
UA95788C2 (en) | 2005-12-15 | 2011-09-12 | Ф. Хоффманн-Ля Рош Аг | Fused pyrrole derivatives |
TW200827336A (en) * | 2006-12-06 | 2008-07-01 | Astrazeneca Ab | New crystalline forms |
US20090061000A1 (en) * | 2007-08-31 | 2009-03-05 | Astrazeneca Ab | Pharmaceutical formulation use 030 |
DE102008007440A1 (de) * | 2008-02-01 | 2009-08-13 | Dritte Patentportfolio Beteiligungsgesellschaft Mbh & Co.Kg | Aminosäurederivate als Arzneistoffe |
JP2011525487A (ja) * | 2008-06-23 | 2011-09-22 | アストラゼネカ アクチボラグ | トロンビン阻害剤としての使用のための新規複素環式カルボキサミド |
CN104327029A (zh) * | 2014-09-21 | 2015-02-04 | 湖南华腾制药有限公司 | 一种含氧杂环化合物的制备方法 |
Family Cites Families (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU178398B (en) | 1979-06-12 | 1982-04-28 | Gyogyszerkutato Intezet | Process for producing new agmatine derivatives of activity against haemagglutination |
HU192646B (en) | 1984-12-21 | 1987-06-29 | Gyogyszerkutato Intezet | Process for preparing new n-alkyl-peptide aldehydes |
CA1341029C (en) | 1985-02-04 | 2000-06-20 | Michael Kolb | Peptidase inhibitors |
US5187157A (en) | 1987-06-05 | 1993-02-16 | Du Pont Merck Pharmaceutical Company | Peptide boronic acid inhibitors of trypsin-like proteases |
EP0362002B1 (en) | 1988-09-01 | 1995-07-26 | Merrell Dow Pharmaceuticals Inc. | HIV protease inhibitors |
ZA897515B (en) | 1988-10-07 | 1990-06-27 | Merrell Dow Pharma | Novel peptidase inhibitors |
TW201303B (no) | 1990-07-05 | 1993-03-01 | Hoffmann La Roche | |
CA2075154A1 (en) | 1991-08-06 | 1993-02-07 | Neelakantan Balasubramanian | Peptide aldehydes as antithrombotic agents |
SE9102462D0 (sv) | 1991-08-28 | 1991-08-28 | Astra Ab | New isosteric peptides |
ZA928581B (en) | 1991-11-12 | 1994-05-06 | Lilly Co Eli | Antithrombotic agents |
SE9103612D0 (sv) | 1991-12-04 | 1991-12-04 | Astra Ab | New peptide derivatives |
JPH08501057A (ja) * | 1992-03-04 | 1996-02-06 | ヂョヂセルクタトー インテーゼット カーエフテー | 新規な抗凝結因子ペプチド誘導体及びそれを含有する製薬学的組成物及びその製造方法 |
TW223629B (no) | 1992-03-06 | 1994-05-11 | Hoffmann La Roche | |
AU675981B2 (en) | 1992-12-02 | 1997-02-27 | Bristol-Myers Squibb Company | Guanidinyl-substituted heterocyclic thrombin inhibitors |
US5583146A (en) | 1992-12-02 | 1996-12-10 | Bristol-Myers Squibb Company | Heterocyclic thrombin inhibitors |
JPH06340619A (ja) | 1993-05-03 | 1994-12-13 | Bristol Myers Squibb Co | グアニジニルまたはアミジニル置換メチルアミノ複素環トロンビン抑制剤 |
US5783563A (en) | 1993-06-03 | 1998-07-21 | Astra Aktiebolag | Method for treatment or prophylaxis of venous thrombosis |
SE9301916D0 (sv) | 1993-06-03 | 1993-06-03 | Ab Astra | New peptides derivatives |
EP0648780A1 (en) | 1993-08-26 | 1995-04-19 | Bristol-Myers Squibb Company | Heterocyclic thrombin inhibitors |
TW394760B (en) | 1993-09-07 | 2000-06-21 | Hoffmann La Roche | Novel Carboxamides, process for their preparation and pharmaceutical composition containing the same |
AU1025795A (en) | 1994-01-27 | 1995-08-03 | Mitsubishi Chemical Corporation | Prolineamide derivatives |
US5705487A (en) | 1994-03-04 | 1998-01-06 | Eli Lilly And Company | Antithrombotic agents |
US5707966A (en) | 1994-03-04 | 1998-01-13 | Eli Lilly And Company | Antithrombotic agents |
US5726159A (en) | 1994-03-04 | 1998-03-10 | Eli Lilly And Company | Antithrombotic agents |
IL112795A (en) | 1994-03-04 | 2001-01-28 | Astrazeneca Ab | Derivatives of peptides as antithrombotic drugs, their preparation, and pharmaceutical preparations containing them |
US5561146A (en) | 1994-06-10 | 1996-10-01 | Bristol-Myers Squibb Company | Modified guanidino and amidino thrombin inhibitors |
DE4421052A1 (de) | 1994-06-17 | 1995-12-21 | Basf Ag | Neue Thrombininhibitoren, ihre Herstellung und Verwendung |
US5510369A (en) | 1994-07-22 | 1996-04-23 | Merck & Co., Inc. | Pyrrolidine thrombin inhibitors |
DE4443390A1 (de) | 1994-12-06 | 1996-06-13 | Basf Ag | Neue dipeptidische p-Amidinobenzylamide mit N-terminalen Sulfonyl- bzw. Aminosulfonylresten |
CN1173872A (zh) | 1995-02-10 | 1998-02-18 | 巴斯福股份公司 | 凝血酶抑制剂 |
NZ302649A (en) | 1995-02-17 | 2000-01-28 | Basf Ag | Dipeptide amidine derivatives, preparation and pharmaceutical compositions thereof |
US5710130A (en) | 1995-02-27 | 1998-01-20 | Eli Lilly And Company | Antithrombotic agents |
US5914319A (en) | 1995-02-27 | 1999-06-22 | Eli Lilly And Company | Antithrombotic agents |
EP0820453A4 (en) | 1995-04-04 | 2001-08-29 | Merck & Co Inc | THROMBIN INHIBITORS |
US5629324A (en) | 1995-04-10 | 1997-05-13 | Merck & Co., Inc. | Thrombin inhibitors |
SA96170106A (ar) | 1995-07-06 | 2005-12-03 | أسترا أكتيبولاج | مشتقات حامض أميني جديدة |
TW541316B (en) | 1995-12-21 | 2003-07-11 | Astrazeneca Ab | Prodrugs of thrombin inhibitors |
AU1990197A (en) | 1996-03-12 | 1997-10-01 | Bristol-Myers Squibb Company | Carbamyl guanidine and amidine prodrugs |
JPH1095898A (ja) | 1996-09-25 | 1998-04-14 | Sumitomo Bakelite Co Ltd | 難燃性樹脂組成物およびこれを用いた積層板 |
SE9602263D0 (sv) | 1996-06-07 | 1996-06-07 | Astra Ab | New amino acid derivatives |
SE9602646D0 (sv) | 1996-07-04 | 1996-07-04 | Astra Ab | Pharmaceutically-useful compounds |
DE19632772A1 (de) | 1996-08-14 | 1998-02-19 | Basf Ag | Neue Benzamidine |
DE19632773A1 (de) | 1996-08-14 | 1998-02-19 | Basf Ag | Neue Thrombininhibitoren |
AR013084A1 (es) * | 1997-06-19 | 2000-12-13 | Astrazeneca Ab | Derivados de amidino utiles como inhibidores de la trombina, composicion farmaceutica, utilizacion de dichos compuestos para la preparacion demedicamentos y proceso para la preparacion de los compuestos mencionados |
-
1998
- 1998-06-05 AR ARP980102696A patent/AR013084A1/es not_active Application Discontinuation
- 1998-06-09 AT AT98929969T patent/ATE277902T1/de not_active IP Right Cessation
- 1998-06-09 EE EEP199900600A patent/EE9900600A/xx unknown
- 1998-06-09 CN CNB988081172A patent/CN1205187C/zh not_active Expired - Fee Related
- 1998-06-09 DE DE69826693T patent/DE69826693T2/de not_active Expired - Fee Related
- 1998-06-09 WO PCT/SE1998/001103 patent/WO1998057932A1/en active IP Right Grant
- 1998-06-09 SK SK1670-99A patent/SK167099A3/sk unknown
- 1998-06-09 BR BR9810177-3A patent/BR9810177A/pt not_active Application Discontinuation
- 1998-06-09 JP JP50426299A patent/JP3919236B2/ja not_active Expired - Fee Related
- 1998-06-09 AU AU79461/98A patent/AU737645C/en not_active Ceased
- 1998-06-09 TR TR1999/03134T patent/TR199903134T2/xx unknown
- 1998-06-09 EP EP98929969A patent/EP1012140B1/en not_active Expired - Lifetime
- 1998-06-09 NZ NZ501635A patent/NZ501635A/en unknown
- 1998-06-09 KR KR1019997012009A patent/KR100540413B1/ko not_active IP Right Cessation
- 1998-06-09 PL PL98337645A patent/PL337645A1/xx not_active Application Discontinuation
- 1998-06-09 US US09/091,994 patent/US6265397B1/en not_active Expired - Fee Related
- 1998-06-09 IL IL13349098A patent/IL133490A0/xx not_active IP Right Cessation
- 1998-06-09 CA CA002294059A patent/CA2294059C/en not_active Expired - Fee Related
-
1999
- 1999-12-15 IS IS5302A patent/IS5302A/is unknown
- 1999-12-17 NO NO19996313A patent/NO315156B1/no not_active IP Right Cessation
-
2001
- 2001-04-30 US US09/844,428 patent/US6576657B2/en not_active Expired - Fee Related
-
2006
- 2006-07-10 JP JP2006188906A patent/JP2006321807A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2006321807A (ja) | 2006-11-30 |
AR013084A1 (es) | 2000-12-13 |
IS5302A (is) | 1999-12-15 |
US6576657B2 (en) | 2003-06-10 |
EP1012140B1 (en) | 2004-09-29 |
IL133490A0 (en) | 2001-04-30 |
CA2294059C (en) | 2008-12-09 |
CN1205187C (zh) | 2005-06-08 |
EE9900600A (et) | 2000-08-15 |
JP2002503256A (ja) | 2002-01-29 |
US20020022612A1 (en) | 2002-02-21 |
AU737645B2 (en) | 2001-08-23 |
BR9810177A (pt) | 2000-08-08 |
NO315156B1 (no) | 2003-07-21 |
WO1998057932A1 (en) | 1998-12-23 |
KR20010013982A (ko) | 2001-02-26 |
AU7946198A (en) | 1999-01-04 |
SK167099A3 (en) | 2000-06-12 |
US6265397B1 (en) | 2001-07-24 |
TR199903134T2 (xx) | 2000-07-21 |
EP1012140A1 (en) | 2000-06-28 |
DE69826693D1 (de) | 2004-11-04 |
DE69826693T2 (de) | 2006-02-16 |
NO996313L (no) | 2000-02-21 |
AU737645C (en) | 2002-03-21 |
KR100540413B1 (ko) | 2006-01-12 |
PL337645A1 (en) | 2000-08-28 |
CA2294059A1 (en) | 1998-12-23 |
NZ501635A (en) | 2001-09-28 |
CN1266427A (zh) | 2000-09-13 |
ATE277902T1 (de) | 2004-10-15 |
JP3919236B2 (ja) | 2007-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO986180D0 (no) | Nye amidinoderivater og deres anvendelse som trombininhibitorer | |
NO996313L (no) | Nye amidinoderivater og deres anvendelse som trombininhibitorer | |
DK0836615T3 (da) | Nye thrombininhibitorer, deres fremstilling og anvendelse | |
NO991922L (no) | Heteroarylsuccinamider og deres anvendelse som metalloproteinaseinhibitorer | |
DK0910573T3 (da) | Nye aminosyrederivater og deres anvendelse som thrombininhibitorer | |
NO992492D0 (no) | Benzamidoaldehyder og deres anvendelse som cystein-protease-inhibitorer | |
DK1133477T3 (da) | Substituerede benzimidazoler og deres anvendelse som parpinhibitorer | |
NO973764L (no) | Nye dipeptidamidiner som trombin-inhibitorer | |
NO975740L (no) | Arylsulfonylaminobenzenderivater og deres anvendelse som faktor Xa-inhibitorer | |
NO20014135D0 (no) | Nye sulfonamidforbindelser og deres anvendelse | |
DK0832082T3 (da) | N-heteroaryl-pyridinsulfonamidderivater og deres anvendelse som endotelinantagonister | |
NO20026010D0 (no) | Substituerte quinazolinderivater og deres anvendelse som inhibitorer | |
DK1347955T3 (da) | Nye mandelsyrederivater og deres anvendelse som throbin-hæmmere | |
NO20001323D0 (no) | Dipeptid-apoptose inhibitorer og deres anvendelse | |
DK0989121T3 (da) | Substituerede benzamider og deres anvendelse som immunmodulatorer | |
DK1150996T3 (da) | Nye amidinobenzylaminderivater og deres anvendelse som thrombin-inhibitorer | |
NO994510D0 (no) | Substituerte isokinolin-derivater og deres anvendelse som antikonvulsanter | |
NO995513L (no) | N-triazolyl-2-indolkarboksamider og deres anvendelse som CCK- | |
NO20025504L (no) | Nye tiokromanderivater og anvendelse derav som trombininhibitorer | |
DK1214302T3 (da) | Substituerede 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-oner og deres anvendelse som lipasehæmmere | |
NO20023951D0 (no) | Arylpiperaziner og arylpiperidiner og deres anvendelse som metalloproteinaseinhiberende midler | |
ATE228122T1 (de) | Umgekehrt hydroxamat inhibitoren von matrix metalloproteinasen | |
NO20003128D0 (no) | Nye p-aminofenylderivater og deres anvendelse | |
NO20011654L (no) | Benzamidderivater som trombininhibitorer | |
DK0920330T3 (da) | hCG og derivater som inhibitorer af matrixmetalloproteaser |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |